Reproductive and Therapeutic Cloning Overview

Overview

• Podcast explains reproductive cloning and therapeutic cloning.
• Focuses on purposes, basic methods (somatic cell nuclear transfer), and potential applications.
• Ethical discussion left to students and class; instructor encourages independent investigation.

Reproductive Cloning

• Purpose: create an exact genetic copy of an organism.
• Achieved in plants and animals; landmark example: Dolly the sheep.
• Potential applications:
  • Breed-specific animals or plants with desirable traits.
  • Produce organisms that make medicines or novel nutrients.
  • Potentially repopulate endangered species.
• Main technique: somatic cell nuclear transfer (SCNT).
  • Remove nucleus from egg cell (enucleated oocyte); oocyte still contains RNA, mitochondria, organelles.
  • Remove diploid nucleus from a somatic cell (e.g., udder cell).
  • Insert somatic diploid nucleus into enucleated oocyte.
  • Stimulate with electrical or chemical shock to trigger division.
  • Embryo develops; inner cell mass forms embryo; outer cells form supporting tissues (amnion, umbilical cord, yolk sac).
  • Implant embryo into surrogate uterus for full organism development.
• Key point: any somatic cell can provide the diploid nucleus, not just reproductive cells.

Therapeutic Cloning

• Purpose: harvest embryonic stem cells for clinical use, not to produce a whole organism.
• Process mirrors SCNT up to embryo formation:
  • Create embryo via SCNT.
  • Remove inner cell mass and culture embryonic stem cells in vitro.
  • Differentiate stem cells into specific cell types, tissues, or possibly organs.
• Clinical advantages:
  • Stem-cell-derived tissues/organs can be genetically matched to the donor, reducing transplant rejection.
  • Potential to grow patient-specific skin, organs, or other tissues for therapy.
• Current alternatives and advances:
  • Induced pluripotent stem cells (iPSCs): reprogramming a patient’s somatic cell (e.g., skin cell) by overexpressing a few key genes to create embryonic-like stem cells.
  • iPSCs avoid the need for donor oocytes and can produce patient-matched stem cells.

Key Terms And Definitions

• Somatic Cell Nuclear Transfer (SCNT): transfer of a diploid nucleus from a somatic cell into an enucleated oocyte to produce an embryo.
• Enucleated Oocyte: egg cell with its nucleus removed; retains cytoplasm, RNA, mitochondria, and organelles.
• Diploid Nucleus: nucleus containing two sets of chromosomes (from somatic cell).
• Inner Cell Mass (ICM): group of undifferentiated cells in an early embryo that become the embryo proper.
• Embryonic Stem Cells: pluripotent cells derived from the inner cell mass capable of forming many cell types.
• Induced Pluripotent Stem Cells (iPSCs): somatic cells reprogrammed to an embryonic-like pluripotent state by expressing specific genes.

Process Summary Table

Advantages, Risks, And Considerations

• Advantages:
  • Reproductive cloning: replicate desirable genotypes, preserve species.
  • Therapeutic cloning/iPSCs: produce patient-specific tissues, reduce rejection.
• Risks and ethical issues:
  • Controversial ethical concerns surrounding embryo use and human applications.
  • Technical challenges: organ construction complexity and long-term safety.
  • Rejection is reduced but not necessarily eliminated; clinical risks remain.

Action Items / Next Steps

• Investigate ethical, legal, and social implications of cloning technologies.
• Review advanced topics for deeper understanding: molecular genetics, epigenetics, iPSC reprogramming.
• Bring questions to class for discussion on benefits and dangers.